Naxicap Partners becomes the majority shareholder of Lagarrigue Group
Naxicap Partners has acquired a majority stake in Lagarrigue Group.
As one of the top private equity firms in France, Naxicap Partners – an affiliate of Natixis Investment Managers – has US$4.8 billion in assets under management. As a committed, responsible investor, Naxicap Partners builds solid, constructive partnerships with entrepreneurs so that their projects can succeed. The firm has 39 investment professionals spread across five offices in Paris, Lyon, Toulouse and Nantes in France, and Frankfurt in Germany.
Lagarrigue Group is a global specialist in external orthopedic devices (prostheses/orthoses) and in the design and manufacture of custom-made large orthopedic devices (LAD) for the treatment of disabilities. Lagarrigue is an international player, thanks to a very active external growth strategy that has led to nearly 25 acquisitions since 2016.
Ardian is one of the world’s leading private equity firms with US$110 billion under management and/or advisory in Europe, America and Asia. The firm, majority-owned by its employees, places entrepreneurship at the heart of its approach and offers its international investors top-tier performance.
Oaklins’ team in France acted as advisor to Naxicap Partners in this transaction.
Talk to the deal team
Related deals
Dolmans Landscaping Group has welcomed Foreman Capital as a new shareholder to support further growth
Dolmans Landscaping Group, a leading full-service provider of landscaping services, has welcomed Foreman Capital as a new shareholder. By partnering with Foreman Capital, which has extensive experience in building stronger companies in the maintenance of public spaces, Dolmans can accelerate its growth trajectory across core verticals and further professionalize the business.
Learn moreBackspin has completed a mandatory public tender offer for the shares of Spindox
Backspin S.p.A. has completed a mandatory public tender offer for Spindox S.p.A.
Learn moreRare Patient Voice has been acquired by Konovo
Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.
Learn more